Combination Chemotherapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

You may be eligible if

• DISEASE CHARACTERISTICS:
• Histologically confirmed stage IC-IV ovarian epithelial, fallopian tube, or peritoneal carcinoma
• * No tumors of low-malignant potential (borderline tumors)
• No symptomatic brain metastases
• PATIENT CHARACTERISTICS:
• Age:
• 18 and over
• Performance status:
• ECOG 0-2 OR
• Karnofsky 70-100%
• Life expectancy:
• At least 6 months
• Hematopoietic:
• WBC at least 3,000/mm\^3
• Absolute neutrophil count at least 1,500/mm\^3
• Platelet count at least 100,000/mm\^3
• Hemoglobin greater than 10 g/dL
• Hepatic:
• Bilirubin no greater than 2 times upper limit of normal
• Renal:
• Glomerular filtration rate at least 60 mL/min
• Cardiovascular:
• No history of congestive heart failure (New York Heart Association class III or IV heart disease) even if medically controlled
• No myocardial infarction within the past 6 months
• No history of atrial or ventricular arrhythmias
• Neurologic:
• No history of seizure disorder
• No history of CNS disorder
• No pre-existing motor or sensory neuropathy or symptoms grade 2 or greater
• Other:
• No severe concurrent infection
• No prior hypersensitivity reaction to products containing Cremophor EL or compounds chemically related to carboplatin, paclitaxel, or gemcitabine
• No complete bowel obstruction
• No other concurrent severe medical problems that would preclude study
• Not pregnant or nursing
• Negative pregnancy test
• Fertile patients must use effective contraception
• PRIOR CONCURRENT THERAPY:
• Biologic therapy:
• No concurrent immunotherapy
• No concurrent WBC transfusions
• Chemotherapy:
• No prior chemotherapy
• No other concurrent chemotherapy
• Endocrine therapy:
• No concurrent hormonal therapy except replacement therapy or steroid antiemetics
• Radiotherapy:
• No prior radiotherapy
• No concurrent radiotherapy
• Surgery:
• No more than 6 weeks since prior definitive surgery